SB 240 Kentucky Senate · 2025 Regular Session

AN ACT relating to Ibogaine research in the Commonwealth.

Summary
Create new sections of KRS 218A to define terms; establish the intent of the General Assembly that ibogaine is worthy of clinical research, trials, and studies as a potential viable therapeutic treatment of opioid dependence and any other co-occurring mental health disorders; establish a trust and agency account entitled the ibogaine research fund; establish a process for private entities to apply to the Department of Agriculture for access to funds in the Ibogaine Research Fund.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 18, 2025 Last action Feb 20, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Feb 20, 2025
Committee
to Health Services (S)
upper
Feb 18, 2025
Committee
to Committee on Committees (S)
upper
Feb 18, 2025
Introduced
introduced in Senate
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.